Skip to main content

Advertisement

Table 2 Antiretroviral treatment used in ninety-five HIV-1-infected patients

From: Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients

Antiretroviral drugs Number of patients (%)
TDF 75 (78.9)
ABC 12 (12.6)
3TC 12 (12.6)
FTC 76 (80)
NVP 12 (12.6)
EFV 36 (37.8)
LPV/RTV 5 (5.2)
ATV/RTV 13 (13.6)
ATV 4 (4.2)
DRV/RTV 16 (16.8)
RAL 10 (10.5)
MVC 2 (10.5)
  1. TDF, tenofovir; ABC, abacavir; 3TC, lamivudine; FTC, emtricitabine; NVP, nevirapine; EFV, efavirenz; LPV/RTV, lopinavir/ritonavir; ATV/RTV, atazanvir/ritonavir; DRV/RTV, darunavir/ritonavir; RAL, raltegravir; MVC, maraviroc. All data are expressed as number (%) of patients.